CAJ | 학술논문

目的：探讨腹腔镜下病灶切除术联合米非司酮治疗子宫腺肌瘤的临床效果。方法收集本院2008年1月至2012年8月子宫腺肌瘤患者58例为研究对象，按照治疗方法不同将其分为开腹组（开腹子宫腺肌瘤切除术）和腹腔镜组（腹腔镜子宫腺肌瘤切除术），术后1周内两组患者均口服米非司酮，12.5 mg/d，1次/天，连续服用3个月。比较两组患者手术时间、术中出血量、术后肛门排气时间、住院时间、并发症发生率、痛经改善及复发情况。结果腹腔镜组患者手术时间、肛门排气时间、住院时间均短于开腹组（P＜0.05），术中出血量少于开腹组（P＜0.05）术后并发症发生率、复发率均明显低于开腹组（P＜0.05），痛经改善率高于开腹组（P＜0.05）。结论腹腔镜下病灶切除术联合米非司酮治疗子宫腺肌瘤，疗效肯定，安全性高。
목적：탐토복강경하병조절제술연합미비사동치료자궁선기류적림상효과。방법수집본원2008년1월지2012년8월자궁선기류환자58례위연구대상，안조치료방법불동장기분위개복조（개복자궁선기류절제술）화복강경조（복강경자궁선기류절제술），술후1주내량조환자균구복미비사동，12.5 mg/d，1차/천，련속복용3개월。비교량조환자수술시간、술중출혈량、술후항문배기시간、주원시간、병발증발생솔、통경개선급복발정황。결과복강경조환자수술시간、항문배기시간、주원시간균단우개복조（P＜0.05），술중출혈량소우개복조（P＜0.05）술후병발증발생솔、복발솔균명현저우개복조（P＜0.05），통경개선솔고우개복조（P＜0.05）。결론복강경하병조절제술연합미비사동치료자궁선기류，료효긍정，안전성고。
ObjectiveTo evaluate the clinical results of the laparoscopic resection combined with mifepristone in the treatment of endometrioma.Method58 patients with endometrioma in our hospital from January 2008 to August 2012 were collected for the study, they were divided into transabdominal group (transabdominal endometrioma excision) and laparoscopic group (laparoscopic endometrioma excision) according to the different treatment methods, all patients began to use mifepristone after 1 week. Operative time, bleeding volum, postoperative exhausting time, hospital stay, complications rate, dysmenorrhea improvement rate and recurrence rate of the two groups were compared.ResultThe operative time, bleeding volum, postoperative exhausting time, hospital stay of laparoscopic group were shorter than transabdominal group (P<0.05); postoperative complication rate and recurrence rate of laparoscopic group were signiifcantly lower than transabdominal group (P<0.05), and dysmenorrhea improvement rate was higher than transabdominal group (P<0.05).ConclusionLaparoscopic resection combined with mifepristone is effective and safe in the treatment of endometrioma.